Inflammation is the common mechanism of diseases (CMD) in COVID-19 disease during pregnancy and in gestational diabetes mellitus
The Regional Cooperation for Health, Science and Technology (RECOOP HST) Consortium, led by Cedars-Sinai Medical Center was formed in 2006, was transformed into an Association in 2012 and includes 17 universities and academic organizations from eight countries: seven in Central and Eastern Europe (C...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry
2021-04-01
|
Series: | The Ukrainian Biochemical Journal |
Subjects: | |
Online Access: | http://ukrbiochemjournal.org/wp-content/uploads/2021/05/Vari_SG_2_21.pdf |
_version_ | 1797427430895386624 |
---|---|
author | Sandor G. Vari |
author_facet | Sandor G. Vari |
author_sort | Sandor G. Vari |
collection | DOAJ |
description | The Regional Cooperation for Health, Science and Technology (RECOOP HST) Consortium, led by Cedars-Sinai Medical Center was formed in 2006, was transformed into an Association in 2012 and includes 17 universities and academic organizations from eight countries: seven in Central and Eastern Europe (Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Ukraine) and the United States. RECOOP builds multinational, multidisciplinary collaborations, and assists as well as coordinates the research activities of the sixteen research groups that are the Cedars-Sinai Medical Center – RECOOP Research Centers (CRRCs). https://www.cedars-sinai.org/research/administration/recoop.html.
Implementations of RECOOP’s strategic goals enable diverse talents geared towards integration of new knowledge derived from multiple specialties to investigate Common Mechanism of Diseases (CMD). While some may consider RECOOP’s CMD research strategy unorthodox, recent and timely scientific evidence shows that inflammation is the triggering event in the change of vascularization and it is the common mechanism of these two diseases: COVID-19 Disease during pregnancy and gestational diabetes mellitus (GDM). |
first_indexed | 2024-03-09T08:44:58Z |
format | Article |
id | doaj.art-843c340bd5504fbaba2e71334f077d9b |
institution | Directory Open Access Journal |
issn | 2409-4943 2413-5003 |
language | English |
last_indexed | 2024-03-09T08:44:58Z |
publishDate | 2021-04-01 |
publisher | National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry |
record_format | Article |
series | The Ukrainian Biochemical Journal |
spelling | doaj.art-843c340bd5504fbaba2e71334f077d9b2023-12-02T15:44:19ZengNational Academy of Sciences of Ukraine, Palladin Institute of BiochemistryThe Ukrainian Biochemical Journal2409-49432413-50032021-04-019325510.15407/ubj93.02.005Inflammation is the common mechanism of diseases (CMD) in COVID-19 disease during pregnancy and in gestational diabetes mellitusSandor G. Vari0https://orcid.org/0000-0003-2962-2017Cedars-Sinai Medical Center, International Research and Innovation in Medicine Program, Los Angeles, California, United StatesThe Regional Cooperation for Health, Science and Technology (RECOOP HST) Consortium, led by Cedars-Sinai Medical Center was formed in 2006, was transformed into an Association in 2012 and includes 17 universities and academic organizations from eight countries: seven in Central and Eastern Europe (Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Ukraine) and the United States. RECOOP builds multinational, multidisciplinary collaborations, and assists as well as coordinates the research activities of the sixteen research groups that are the Cedars-Sinai Medical Center – RECOOP Research Centers (CRRCs). https://www.cedars-sinai.org/research/administration/recoop.html. Implementations of RECOOP’s strategic goals enable diverse talents geared towards integration of new knowledge derived from multiple specialties to investigate Common Mechanism of Diseases (CMD). While some may consider RECOOP’s CMD research strategy unorthodox, recent and timely scientific evidence shows that inflammation is the triggering event in the change of vascularization and it is the common mechanism of these two diseases: COVID-19 Disease during pregnancy and gestational diabetes mellitus (GDM).http://ukrbiochemjournal.org/wp-content/uploads/2021/05/Vari_SG_2_21.pdfcomorbiditiescovid diseasecytokinesimmunoglobulinsinflammationpathophysiologyplacentapregnancyvascularization |
spellingShingle | Sandor G. Vari Inflammation is the common mechanism of diseases (CMD) in COVID-19 disease during pregnancy and in gestational diabetes mellitus The Ukrainian Biochemical Journal comorbidities covid disease cytokines immunoglobulins inflammation pathophysiology placenta pregnancy vascularization |
title | Inflammation is the common mechanism of diseases (CMD) in COVID-19 disease during pregnancy and in gestational diabetes mellitus |
title_full | Inflammation is the common mechanism of diseases (CMD) in COVID-19 disease during pregnancy and in gestational diabetes mellitus |
title_fullStr | Inflammation is the common mechanism of diseases (CMD) in COVID-19 disease during pregnancy and in gestational diabetes mellitus |
title_full_unstemmed | Inflammation is the common mechanism of diseases (CMD) in COVID-19 disease during pregnancy and in gestational diabetes mellitus |
title_short | Inflammation is the common mechanism of diseases (CMD) in COVID-19 disease during pregnancy and in gestational diabetes mellitus |
title_sort | inflammation is the common mechanism of diseases cmd in covid 19 disease during pregnancy and in gestational diabetes mellitus |
topic | comorbidities covid disease cytokines immunoglobulins inflammation pathophysiology placenta pregnancy vascularization |
url | http://ukrbiochemjournal.org/wp-content/uploads/2021/05/Vari_SG_2_21.pdf |
work_keys_str_mv | AT sandorgvari inflammationisthecommonmechanismofdiseasescmdincovid19diseaseduringpregnancyandingestationaldiabetesmellitus |